Calibrate

We’re proud to unveil our fourth annual results report, showcasing three years of real-world outcomes and further establishing Calibrate’s position as the only obesity management company delivering longitudinal data of this magnitude. Our annual report highlights NEW data on: -A longitudinal three-year dataset from a real-world cohort -Maintaining weight loss after stopping GLP-1 medication  -Proven health improvements through lifestyle changes alone -Sustainable outcomes for those with disrupted medication access -Continuation of habits learned through Calibrate even after the program ends The 2025 Results Report solidifies Calibrate’s position as the only company offering three years of real-world data that combines GLP-1 medications with intensive lifestyle intervention. We’re proud to set a new standard for sustainable weight management and to redefine what’s possible in obesity care. Check out the comments below for a link to our latest results! #2025ResultsReport #RealOutcomes #WeightManagement

At Calibrate, our mission is to empower sustainable, transformative behavior change—and our members’ feedback speaks volumes. By providing members with effective tools and support, we’re driving lasting change and redefining what’s possible in metabolic health. Learn more about what our members are saying in our 2025 Results Report: https://lnkd.in/eEcnpJJ9 #2025ResultsReport #MemberSatisfaction #SustainableHealth 

At Calibrate, medication is just one tool in a much larger treatment plan. Our data demonstrates impressive weight loss outcomes from members who experienced inconsistent access to GLP-1 medication. On average, Calibrate members filled 8.21 prescriptions in the first 12 months of the program with 72.5% of members experiencing at least one medication disruption. Even members with minimal medication access, defined as a disruption of at least 13 weeks, experienced 13.7% weight loss at 12 months and 15% at 24 months.  #2025ResultsReport #RealOutcomes #WeightManagement

The future of obesity treatment lies in combining powerful drug therapies with clinician-led lifestyle interventions. In this episode, of The Beat podcast, Rob MacNaughton, CEO of Calibrate, discusses the company’s pioneering approach to weight management. He shares how Calibrate blends anti-obesity medications with clinician-led lifestyle interventions to ensure sustainable weight loss outcomes. 🎧 Tune in to learn how Calibrate is transforming obesity care and delivering results that last: https://lnkd.in/g96x2mdy

Backed by three years of data, Calibrate’s Metabolic Reset program demonstrates sustained and clinically significant results, showcasing its long-term effectiveness and impact on our members’ health. Learn more in our 2025 Results Report: https://lnkd.in/edKFHPVA #2025ResultsReport #RealOutcomes #WeightManagement

We’re proud to unveil our fourth annual results report, showcasing three years of real-world outcomes and further establishing Calibrate’s position as the only obesity management company delivering longitudinal data of this magnitude. Our annual report highlights NEW data on: -A longitudinal three-year dataset from a real-world cohort -Maintaining weight loss after stopping GLP-1 medication -Proven health improvements through lifestyle changes alone -Sustainable outcomes for those with disrupted medication access -Continuation of habits learned through Calibrate even after the program ends The 2025 Results Report solidifies Calibrate’s position as the only company offering three years of real-world data that combines GLP-1 medications with intensive lifestyle intervention. We’re proud to set a new standard for sustainable weight management and to redefine what’s possible in obesity care. Learn more about our new 2025 Results Report: https://lnkd.in/eBA3MqDQ #2025ResultsReport #RealOutcomes #WeightManagement

🚨 New Blog Alert! 🚨 Transforming Workplace Health: Insights from Obesity Week 2024 At Obesity Week 2024, Calibrate shared groundbreaking research demonstrating how our program helps members achieve and sustain a healthy BMI of <25—a critical benchmark for reducing metabolic health risks. These findings reaffirm Calibrate’s leadership in delivering measurable outcomes that improve individual health and drive organizational success. From reducing absenteeism and healthcare costs to enhancing productivity, our results show why GLP-1 medications combined with intensive lifestyle interventions (ILI) make all the difference. 💡 Key takeaways from the blog: ✔️ 13.5% of members achieved a BMI of <25 within 12 months. ✔️ Average weight loss: 24.2% at one year, with sustained results over two years. ✔️ ROI up to 3:1 for employers through health and productivity gains. 📊 Why it matters: Obesity costs U.S. employers billions in lost productivity annually. Achieving a BMI <25 isn't just about numbers—it’s about healthier employees and stronger organizations. 🔗 Dive into the research and see how Calibrate is redefining workplace health: https://lnkd.in/eN8bwZfb Let’s build a healthier workforce, together. #ObesityWeek2024 #WorkplaceHealth #EmployeeWellness #GLP1 #SustainableWeightLoss

Providing GLP-1 coverage? A smart step! But if you want to create a lasting impact, it’s crucial to go beyond medication and empower your employees with lifestyle intervention. Imagine increased energy, sharper focus, improved time management, and greater self-confidence—all driving higher productivity and employee satisfaction. Curious how? Explore our latest article on the power of combining GLP-1 with lifestyle intervention. Your employees—and your ROI—will thank you! https://hubs.la/Q02WNY0D0… #EmployeeEngagement #Workplace #HealthAndWellness

We’re excited to unveil the results from our second research poster at #ObesityWeek2024. This poster demonstrates how Calibrate supports members in achieving a BMI of less than 25. 4 key takeaways:  1️⃣ Healthy BMI Achievement: In just 12 months, 13.5% of Calibrate members reached a BMI below 25, the benchmark for reduced metabolic risk factors. 2️⃣ Remarkable Weight Loss & Waist Reduction: Members who achieved a healthy BMI lost an average of 24.2% of their body weight and reduced their waist circumference by 7.64 inches by month 12. 3️⃣ Metabolic Health Gains: These members showed statistically significant improvements in HbA1c, LDL Cholesterol, Triglycerides, ALT, AST, hs-CRP, and insulin—driving meaningful health impact. 4️⃣ Program Engagement: Members reaching a healthy BMI were significantly more engaged in the program, consistently tracking and attending coaching sessions. These findings underscore how Calibrate’s structured approach supports sustainable, measurable health improvements. Stay tuned for more in our 2025 Results Report! #ObesityWeek #GLP1 #WeightManagement #HealthInnovation #MetabolicHealth #DigitalHealth #ProveIt